Overall (N = 87) | Oral (N = 22) | Intravenous (N = 65) | p value | |
---|---|---|---|---|
Female/male | 39 (45%)/48 (55%) | 8 (36%)/14 (64%) | 31 (48%)/34 (52%) | 0.46 |
Age (years) | 40 (24–50) | 39 (25–49) | 40 (24–52) | 0.57 |
Disease duration (years) | 2.9 (1.0–8.3) | 2.5 (0.8–11.5) | 3.0 (1.2–7.8) | 0.95 |
Disease type: extensive /left-sided | 71 (82%)/16 (18%) | 16 (73%)/6 (27%) | 55 (85%)/10 (15%) | 0.18 |
Body mass index | 19.4 (16.9–22.6) | 20.1 (16.6–23.6) | 19.4 (16.8–22.1) | 0.8 |
Lichtiger index | 13 (12–15) | 12 (12–14) | 14 (12–15) | 0.09 |
Endoscopic score (UCEIS) | 6 (5–7) | 6 (4–8) | 6 (5–7) | 0.86 |
Hemoglobin (g/dL) | 11.3 (9.7–12.8) | 12.0 (10.3–13.4) | 11.3 (9.2–12.8) | 0.13 |
Albumin (g/dL) | 3.2 (2.6–3.7) | 3.2 (2.6–3.8) | 3.2 (2.6–3.7) | 0.74 |
C-reactive protein (mg/dL) | 3.1 (1.5–9.0) | 4.2 (2.2–11.8) | 2.8 (1.1–7.4) | 0.06 |
Erythrocyte sedimentation rate (mm/h) | 53 (32–81) | 56 (31–73) | 48 (35–82) | 0.87 |
Creatinine (mg/dL) | 0.7 (0.6–0.8) | 0.7 (0.6–0.8) | 0.7 (0.6–0.8) | 0.83 |
Corticosteroid refractory/dependent | 66 (76%) / 21 (24%) | 16 (73%) / 6 (27%) | 50 (77%) / 15 (23%) | 0.45 |
Biologic agent naive | 61 (70%) | 14 (64%) | 47 (72%) | 0.31 |